In its upcoming report, Haemonetics (HAE) is predicted by Wall Street analysts to post quarterly earnings of $1.01 per share, reflecting a decline of 1$303.28 million, representing a year-over-year decrease of 9.8%. Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial f ...